Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anna Protopapas Insider Profile
11 Followers
Anna Protopapas, Director at Ariad, holds 380.10K shares in Mersana Therapeutics (Ticker: MRSN), holds 0.00 shares in Nuvalent (Ticker: NUVL), holds 3.33K shares in Dicerna Pharma (Ticker: DRNA).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-33.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anna Protopapas holds in companies
Most Profitable Insider Trade
The most profitable trade made by Anna Protopapas
Anna Protopapas's Trading History
Ariad
Feb 16, 2017
―
Uninformative Sell
―
$573.41K
Mersana Therapeutics
Jan 17, 2024
Director
Uninformative Sell
79.67K
$1.32M
Bioverativ Inc
Mar 08, 2018
―
Uninformative Sell
―
$0.00
Dicerna Pharma
Jun 07, 2021
―
Uninformative Buy
―
$127.39K
Nuvalent
Dec 20, 2023
Director
Informative Sell
378.35K
$0.00
List of latest transactions for each holding click on a transaction to see Anna Protopapas's performance on stock
You May Also Like
Anna Protopapas insider profile FAQ
What is the percentage of profitable transactions made by Anna Protopapas?
The percentage of profitable transactions made by Anna Protopapas is 50%.
What is the average return per transaction made by Anna Protopapas?
The average return per transaction made by Anna Protopapas is -33.80%.
What stocks does Anna Protopapas hold?
Anna Protopapas holds: ARIA, MRSN, BIVV, DRNA, NUVL stocks.
What was Anna Protopapas’s latest transaction?
Anna Protopapas latest transaction was an Uninformative Sell of $79.67K.
What was Anna Protopapas's most profitable transaction?
Anna Protopapas’s most profitable transaction was an Informative Sell of NUVL stock on December 20, 2023. The return on the trade was 7.20%.
What is Anna Protopapas's role in Ariad?
Anna Protopapas's role in Ariad is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.